Perceived ambiguity about screening mammography recommendations: Association with future mammography uptake and perceptions

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 3, 2007, Pages 458-466

  Han, Paul K J ^a   Kobrin, Sarah C ^a   Klein, William M P ^b   Davis, William W ^a   Stefanek, Michael ^c   Taplin, Steven H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BEHAVIORAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; PATIENT ATTITUDE; PERCEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REMINDER SYSTEMS; UNCERTAINTY;

EID: 34047258664     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0533     Document Type: Article

References (67)

1. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA 1992;267:2221-6.
2. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-92.
3. Whitney SN. A new model of medical decisions: exploring the limits of shared decision making. Med Decis Making 2003;23:275-80.
4. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004;140: 54-9.
5. Bekker H, Thornton JG, Airey CM, et al. Informed decision making: an annotated bibliography and systematic review. Health Technol Assess 1999; 3:1-156.
6. Kaplan RM. Shared medical decision making. A new tool for preventive medicine. Am J Prev Med 2004;26:81-3.
7. Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004;26: 67-80.
8. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer 2004;101 Suppl 5: 1214-28.
9. Fox RC. The evolution of medical uncertainty. Milbank Mem Fund Q Health Soc 1980;58:1-49.
10. Stocking SH. How journalists deal with scientific uncertainty. In: Friedman SM, Dunwoody S, Rogers CL, eds. Communicating uncertainty: media coverage of new and controversial science. Mahwah (NJ): Lawrence Erlbaum Associates; 1999. p. 23-42.
11. Angela E, Raffle F. Information about screening: is it to achieve high uptake or to ensure informed choice? Health Expect 2001;4:92-8.
12. Jepson RG, Forbes CA, Sowden AJ, Lewis RA. Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expect 2001;4:116-26.
13. Austoker J. Gaining informed consent for screening. Is difficult - but many misconceptions need to be undone. BMJ 1999;319:722-3.
14. Rimer BK. Interventions to increase breast screening. Lifespan and ethnicity issues. Cancer 1994;74:323-8.
15. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156:1333-6.
16. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med 2003;1:22-8.
17. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med 2001;16:391-8.
18. Taplin SH, Urban N, Taylor VM, Savarino J. Conflicting national recommendations and the use of screening mammography: does the physician's recommendation matter? J Am Board Fam Pract 1997;10:88-95.
19. Nekhlyudov L, Ross-Degnan D, Fletcher SW. Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study. J Gen Intern Med 2003;18:182-9.
20. Farrell MH, Murphy MA, Schneider CE. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing. Eff Clin Pract 2002;5:120-9.
21. Han PK, Moser RP, Klein WM. Perceived ambiguity about cancer prevention recommendations: relationship to perceptions of cancer preventability, risk, and worry. J Health Commun 2006;11 Suppl 1:51-69.
22. Ellsberg D. Risk, ambiguity, and the Savage axioms. Q J Econ 1961;75: 643-69.
23. Camerer C, Weber M. Recent developments in modeling preferences: uncertainty and ambiguity. J Risk Uncertain 1992;5:325-70.
24. Frisch D, Baron J. Ambiguity and rationality. J Behav Decis Making 1988;1: 149-57.
25. Viscusi WK. Alarmist decisions with divergent risk information. Econ J 1997; 107:1657-70.
26. Curley SP, Yates JF. An empirical evaluation of descriptive models of ambiguity reactions in choice situations. J Math Psychol 1989;33:397-427.
27. Einhorn HJ, Hogarth RM. Decision making under ambiguity. J Bus 1986;59: S225-50.
28. Furnham A, Ribchester T. Tolerance of ambiguity: a review of the concept, its measurement and applications. Curr Psychol 1995;14:179-99.
29. Sorrentino RM, Roney CJR. The uncertain mind: individual differences in facing the unknown. Philadelphia: Taylor & Francis; 2000.
30. Beck AT, Emery G, Greenberg RC. Anxiety disorders and phobias: a cognitive perspective. New York: Guilford Press; 1986.
31. Calvo MG, Castillo MD. Mood-congruent bias in interpretation of ambiguity: strategic processes and temporary activation. Q J Exp Psychol 1997;50A:163-82.
32. MacLeod C, Cohen IL. Anxiety and the interpretation of ambiguity: a text comprehension study. J Abnorm Psychol 1993;102:238-47.
33. Lawson C, MacLeod C. Depression and the interpretation of ambiguity. Behav Res Ther 1999;37:463-74.
34. Taplin SH, Barlow WE, Ludman E, et al. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J Natl Cancer Inst 2000;92:233-42.
35. Ernster VL. Mammography screening for women aged 40 through 49: a guidelines saga and a clarion call for informed decision making. Am J Public Health 1997;87:1103-6.
36. Aiken LS, Jackson KM, Lapin A. Mammography screening for women under 50: women's response to medical controversy and changing practice guidelines. Womens Health 1998;4:169-97.
37. Rimer BK, Halabi S, Strigo TS, Crawford Y, Lipkus IM. Confusion about mammography: prevalence and consequences. J Womens Health Gend Based Med 1999;8:509-20.
38. Kaluzny AD, Rimer B, Harris R. The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy. J Natl Cancer Inst 1994;86:901-3.
39. Sutton SM, Eisner EJ, Johnston CM. The mammography guideline controversy: where does the consumer fit in? J Am Med Womens Assoc 1994;49:53-9.
40. Taplin SH, Ichikawa L, Buist DS, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 2004;13:225-34.
41. Taplin SH, Montano DE. Attitudes, age, and participation in mammographic screening: a prospective analysis. J Am Board Fam Pract 1993;6:13-23.
42. Nijs HG, Essink-Bot ML, DeKoning HJ, Kirkels WJ, Schroder FH. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000;22:312-6.
43. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78:471-9.
44. Wolf AM, Philbrick JT, Schorling JB. Predictors of interest in prostate-specific antigen screening and the impact of informed consent: what should we tell our patients? Am J Med 1997;103:308-14.
45. Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev 2000;9:1323-8.
46. Myers RE. African American men, prostate cancer early detection examination use, and informed decision-making. Semin Oncol 1999;26:375-81.
47. Demark-Wahnefried W, Strigo T, Catoe K, et al. Knowledge, beliefs, and prior screening behavior among Blacks and Whites reporting for prostate cancer screening. Urology 1995;46:346-51.
48. Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut Al. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev 2004;13:501-10.
49. McCaul KD, Mullens AB. Affect, thought, and self-protective health behavior: the case of worry and cancer screening. In: Suls J, Wallston K, editors. Social psychological foundations of health and illness. Malden (MA): Blackwell Publishers; 2003. p. 137-68.
50. Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005;14: 517-34.
51. Meissner HI, Rimer BK, Davis WW, Eisner EJ, Siegler IC. Another round in the mammography controversy. J Womens Health (Larchmt) 2003;12: 261-76.
52. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975;13:10-24.
53. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211.
54. Woloshin S, Schwartz LM, Byram SJ, Sox HC, Fischhoff B, Welch HG. Women's understanding of the mammography screening debate. Arch Intern Med 2000;160:1434-40.
55. Kruglanski AW, Webster DM. Motivated closing of the mind: "seizing" and "freezing". Psychol Rev 1996;103:263-83.
56. Kahn BE, Sarin RK. Modeling ambiguity in decisions under uncertainty. J Consum Res 1988;15:265-72.
57. Kreuter MW, Holt CL, Skinner CS. Awareness of mammography controversy among lower-income African American women in urban public health centers. J Womens Health (Larchmt) 2004;13:121-2.
58. Schwartz LM, Woloshin S, Fowler FJ, Jr., Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.
59. Schwartz LM, Woloshin S. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA 2002;287:3136-42.
60. Holmes-Rovner M, Charles S. The mammography screening controversy: who and what is heard in the press? Patient Educ Courts 2003;51:75-81.
61. Yanovitzky I, Blitz CL. Effect of media coverage and physician advice on utilization of breast cancer screening by women 40 years and older. J Health Commun 2000;5:117-34.
62. Dobias KS, Moyer CA, McAchran SE, Katz SJ, Sonnad SS. Mammography messages in popular media: implications for patient expectations and shared clinical decision-making. Health Expect 2001;4:131-9.
63. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 1997;127:966-72.
64. Weinstein ND, Nicolich M. Correct and incorrect interpretations of correlations between risk perceptions and risk behaviors. Health Psychol 1993;12:235-45.
65. Ritov I, Baron J. Reluctance to vaccinate: omission bias and ambiguity. J Behav Decis Making 1990;3:263-77.
66. Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J. Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol 1996;49:697-703.
67. Viscusi WK, Magat WA, Huber J. Communication of ambiguous risk information. Theory Decision 1991;31:159-73.